Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123038) titled 'A study on median effective dose of oliceridine combined with propofol for inhibiting responses to fiberoptic bronchoscopy in young and elderly patients in the ICU' on April 21.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Tianjin Medical University General Hospital
Condition:
Postoperative analgesia
Intervention:
non-elderly group:Intravenous propofol and oliceridine were administered to induce moderate to deep sedation, with each drug delivered within 30+/-5 seconds. The induction dose of propofol was 0.5mg/kg. The dose of oliceridine was determined using Dixon's u...